Aller au contenu principal
Accès ouvert déclaré 2020 article

First Comparison Report of the SAPIEN S3 Ultra Balloon Expandable Transcatheter Heart Valve

4Citations signalées, ce qui n’est pas une note de qualité
3Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Background Even mild paravalvular leak (PVL) is associated with worse quality of life and increased mortality. The Ultra transcatheter heart valve (THV) is intentionally designed to reduce PVL. However, there are limited data comparing the degree of PVL between S3 and Ultra THVs. We compared the degree of PVL between the SAPIEN S3 Ultra (Ultra) and SAPIEN S3 (S3) THV.Methods Transcatheter aortic valve replacement (TAVR) patients who received an S3 or Ultra THV from September 1, 2017 to August 15, 2019 were identified. The THV oversizing percentage, the LVOT calcification and annular calcific nodularity were measured on a blinded re-review of pre-TAVR CTs. The degree of PVL was assessed on a blinded re-review of post-implantation echocardiograms. The demographics, pre-TAVR anatomic characteristics, and degree of PVL were compared between the S3 and Ultra groups using standard statistical methods.Results Thirty-two cases met the inclusion criteria for each group. There were no significant differences in baseline anatomic characteristics or in post-implant mean pressure gradient. There was a trend toward increased balloon post-dilations in the S3 group. There was no moderate or severe PVL in any case. There was significantly less mild PVL in the Ultra group compared to the S3 group (22% vs. 0%, P = 0.006).Conclusion The new generation Edwards SAPIEN S3 Ultra valve is associated with significantly less PVL with similar post-implant hemodynamics in comparison to the previous generation THV.Abbreviations TAVR: Transcatheter Aortic Valve Replacement; THV: Transcatheter Heart Valve; PVL: Paravalvular Leak; S3: Edwards SAPIEN S3 Transcatheter Heart Valve; Ultra: Edwards SAPIEN S3 Ultra Transcatheter Heart Valve; SHIRB: Sutter Health Institutional Review Board; CT: Computed Tomography; TTE: Transthoracic Echocardiogram; LVOT: Left Ventricular Outflow Tract; MPG: Mean Transaortic Pressure Gradient; Vmax: MaximumTransaortic Velocity; PET: Polyethylene Terephthalate

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
First Comparison Report of the SAPIEN S3 Ultra Balloon Expandable Transcatheter Heart Valve
Date Crossref
01/11/2020
Éditeur
Elsevier BV
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Cardiac Valve Diseases and TreatmentsInfective Endocarditis Diagnosis and ManagementCardiac Imaging and Diagnostics

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.